Plecanatide
Trulance Immediate Release is a prescription oral tablet containing plecanatide 3mg, manufactured by Salix Pharmaceuticals Inc. It acts as a guanylate cyclase-C agonist to help with bowel movements in adults with chronic idiopathic constipation. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Trulance Immediate Release is a prescription oral tablet containing plecanatide 3mg, manufactured by Salix Pharmaceuticals Inc. It acts as a guanylate cyclase-C agonist to help with bowel movements in adults with chronic idiopathic constipation. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Plecanatide",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Plecanatide — ANDA 208745 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208745"
}
]
|
| identifier | ANDA208745 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-safety",
"fda",
"pharmaceuticals",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Plecanatide |
